Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study (2015)
- Authors:
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; DOREA, EGIDIO LIMA - HU ; PINTO, GELBA ALMEIDA - HU ; GUSUKUMA, MARIA CECILIA - HU ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: FCF; HU
- Subjects: COLESTEROL; POLIMORFISMO
- Language: Inglês
- Imprenta:
- Source:
- Título: International Journal of Clinical and Experimental Medicine
- ISSN: 1940-5901
- Volume/Número/Paginação/Ano: v. 8, n. 4, p. 5978-5988, 2015
-
ABNT
ZAMBRANO, Tomás et al. Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study. International Journal of Clinical and Experimental Medicine, v. 8, n. 4, p. 5978-5988, 2015Tradução . . Disponível em: http://www.ijcem.com/files/ijcem0006450.pdf. Acesso em: 28 dez. 2025. -
APA
Zambrano, T., Hirata, M. H., Cerda, A., Dórea, E. L., Pinto, G. A., Gusukuma, M. C., et al. (2015). Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study. International Journal of Clinical and Experimental Medicine, 8( 4), 5978-5988. Recuperado de http://www.ijcem.com/files/ijcem0006450.pdf -
NLM
Zambrano T, Hirata MH, Cerda A, Dórea EL, Pinto GA, Gusukuma MC, Bertolami MC, Salazar LA, Hirata RDC. Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study [Internet]. International Journal of Clinical and Experimental Medicine. 2015 ; 8( 4): 5978-5988.[citado 2025 dez. 28 ] Available from: http://www.ijcem.com/files/ijcem0006450.pdf -
Vancouver
Zambrano T, Hirata MH, Cerda A, Dórea EL, Pinto GA, Gusukuma MC, Bertolami MC, Salazar LA, Hirata RDC. Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study [Internet]. International Journal of Clinical and Experimental Medicine. 2015 ; 8( 4): 5978-5988.[citado 2025 dez. 28 ] Available from: http://www.ijcem.com/files/ijcem0006450.pdf - Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe
- Impact of cholesterol-lowering therapies on gene expression of adhesion molecules in mononuclear cells from hypercholesterolemic patients
- Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients
- Factors associated with statin-related muscular adverse events in adult dyslipidemic outpatients
- Downregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol
- Dowregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol
- Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases
- Physician-pharmacist collaborative intervention in the drug therapy optimization in patients with type 2 diabetes
- Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response
- Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
